Study to evaluate the pharmacokinetics of CIN-107 in subjects with varying degrees of renal function

Trial Identifier:	CIN-107-113
Sponsor:	AstraZeneca
NCTID::	NCT05470725
Start Date:	January 2021
Primary Completion Date:	April 2021
Study Completion Date:	April 2021
Condition:	Hypertension

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States, Florida	Orlando, Florida, United States, 32809
United States, Florida	Tampa, Florida, United States, 33603

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.